CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) vs Theriva Biologics, Inc. (TOVX)

CollPlant Biotechnologies Ltd. Sponsored ADR and Theriva Biologics, Inc. are both Biotechnology companies. CollPlant Biotechnologies Ltd. Sponsored ADR and Theriva Biologics, Inc. are of similar size ($7.7M and $7.5M). Theriva Biologics, Inc. has the higher net margin (0.00% vs −3,934.9%) and the lower return on invested capital (−301.7% vs 0.00%). Across the 14 metrics below, Theriva Biologics, Inc. leads on 10 and CollPlant Biotechnologies Ltd. Sponsored ADR on 4.

Valuation

Metric CLGN TOVX Biotechnology median
P/E n/m n/m 10.26
P/S 18.24 n/m 9.18
P/B 1.97 0.60 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.20 0.65
EV/Sales 26.12 n/m 8.98
Earnings yield (235.64%) (430.94%) (34.89%)
Free cash flow yield (193.83%) (174.05%) (24.52%)

Profitability

Metric CLGN TOVX Biotechnology median
Gross margin (321.70%) 0.00% 65.16%
Operating margin (3,900.94%) 0.00% 0.00%
Net margin (3,934.91%) 0.00% 0.00%
Free cash flow margin (3,522.64%) 0.00% 0.00%
Return on equity (161.98%) (115.11%) (50.12%)
Return on assets (101.59%) (37.14%) (45.60%)
Return on invested capital 0.00% (301.72%) 0.00%

Growth

Metric CLGN TOVX Biotechnology median
Revenue growth (TTM) (86.76%) — 6.26%
EPS growth (last fiscal year) 35.17% 89.07% 29.88%
Revenue growth, 5-year CAGR (17.32%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLGN TOVX Biotechnology median
Debt to equity 0.00 0.13 0.00
Current ratio 1.57 1.13 4.89
Net debt to EBITDA 0.56 0.48 1.01

Dividend

Metric CLGN TOVX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CLGN TOVX Biotechnology median
Market cap 7.45m 7.73m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack